Mettler-Toledo International Inc. is set to announce its fiscal fourth-quarter earnings for 2025, with analysts expecting a profit of $12.76 per share, up 2.8% from the year-ago quarter. The company has consistently exceeded Wall Street’s EPS estimates in its last four quarterly reports.

Analysts forecast MTD to report full-year EPS of $42.16, a 2.6% increase from fiscal 2024. The company’s EPS is projected to rise 8.7% year over year to $45.81 in fiscal 2026. MTD stock has outperformed the S&P 500 Index and the Health Care Select Sector SPDR Fund over the past 52 weeks.

MTD’s strong performance in the Industrial and Laboratory segments, particularly in the Americas, has been driven by product launches, bioprocessing demand, and service expansion. Despite tariff-related margin pressures, strategic investments and service expansion have contributed to the company’s outperformance.

After reporting Q3 results, MTD shares fell slightly despite adjusted EPS of $11.15 beating Wall Street expectations. The company’s revenue exceeded forecasts, with full-year adjusted EPS expected to be in the range of $42.05 to $42.25. Analysts hold a moderately bullish consensus opinion on MTD stock.

Read more at Yahoo Finance: Here’s What to Expect From Mettler-Toledo’s Next Earnings Report